Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs

Substance Abuse

Volumn 37, Issue 1, 2016, Pages 118-126

  Oliva, Elizabeth M ^a,b   Nevedal, Andrea ^a   Lewis, Eleanor T ^a,b   McCaa, Matthew D ^a   Cochran, Michael F ^a,c   Konicki, P Eric ^d,e   Davis, Corey S ^f   Wilder, Christine ^g,h  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b Program Evaluation and Resource Center Department of Veteran Affairs   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Network for Public Health Law   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Heroin; homeless; legal; naloxone; narcan; opioids; overdose; residential treatment; substance use disorder

Indexed keywords

NALOXONE; NARCOTIC ANTAGONIST;

ADULT; AGED; DRUG OVERDOSE; EDUCATION; FEMALE; GOVERNMENT; HEALTH CARE DELIVERY; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT EDUCATION; PATIENT SATISFACTION; PSYCHOLOGY; UNITED STATES; VETERAN; YOUNG ADULT;

ADULT; AGED; DRUG OVERDOSE; FEMALE; FOCUS GROUPS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; YOUNG ADULT;

EID: 84961675670     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2015.1129528     Document Type: Article

References (47)

1. Warner M, Hedegaard H, Chen L. Trends in Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999-2012. NCHS Health E-Stat. Available at: http://www.cdc.gov/nchs/data/hestat/drug-poisoning/drug-poisoning-deaths-1999-2012.pdf. Published December 2014. Accessed August 1, 2015.
2. Hedegaard H, Chen L, Warner M. Drug-Poisoning Deaths Involving Heroin: United States, 2000-2013. NCHS Data Brief, no 190. Available at: http://www.cdc.gov/nchs/data/databriefs/db190.pdf. Published 2015. Accessed August 1, 2015.
3. Levi J, Segal L, Martin A. The Facts Hurt: A State-By-State Injury Prevention Policy Report 2015. Washington, DC: Trust for America's Health, Robert Wood Johnson Foundation; 2015.
4. Chen LH, Hedegaard H, Warner M. Rates of deaths from drug poisoning and drug poisoning involving opioid analgesics-United States 1999-2013. MMWR Morb Mortal Wkly Rep. 2015; 64: 32.
5. Bohnert AS, Ilgen MA, Galea S, McCarthy JF, Blow FC. Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System. Med Care. 2011; 49: 393-396.
6. Compton WM, Volkow ND, Throckmorton DC, Lurie P. Expanded access to opioid overdose intervention: research, practice, and policy needs. Ann Intern Med. 2013; 158: 65-66.
7. US Department of Health and Human Services. Actions to address opioid-drug-related overdoses and deaths. J. Pain Palliat Care Pharmacother. 2015; 29: 133-139.
8. Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. HHS Publication No. (SMA) 13-4742.
9. United Nations Office on Drugs and Crime. Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality. New York: United Nations; 2013.
10. World Health Organization. Community Management of Opioid Overdose. Geneva, Switzerland: World Health Organization; 2014.
11. Seal KH, Downing M, Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: A survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003; 80: 291-301.
12. Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008; 103: 1648-1657.
13. Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J Addict Dis. 2006; 25: 89-96.
14. Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008; 43: 858-870.
15. Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health. 2005; 82: 303-311.
16. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: Training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009; 20: 131-136.
17. Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010; 21: 186-193.
18. Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64: 631-635.
19. Wheeler E, Davidon PJ, Jones TS, Florenze KS. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61: 101-105.
20. Role of Naloxone in Opioid Overdose Fatality Prevention. Food and Drug Administration, Center for Drug Evaluation and Research, Office of the Assistant Secretary for Health, National Institute on Drug Abuse; and the Centers for Disease Control and Prevention. http://www.fda.gov/Drugs/NewsEvents/ucm277119.htm. Public Workshop. April 12, 2012.
21. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013; 346: f174.
22. Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013; 158: 1-9.
23. Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007; 84: 126-136.
24. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose education and naloxone for patients prescribed opioids in primary care: A qualitative study of primary care staff. J Gen Intern Med. 2015; 30(12):1837-44. doi: 10.1007/s11606-015-3394-3
25. Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003; 80: 288-290.
26. Matheson C, Pflanz-Sinclair C, Aucott L, et al. Reducing drug related deaths: A pre-implementation assessment of knowledge,barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12. doi: 10.1186/1471-2296-15-12
27. Neale J, Strang J. Naloxone-does over-Antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose. Addiction. 2015;110(10):1644-52. doi: 10.1111/add.13027
28. Green TC, Bowman SE, Ray M, McKenzie M, Lord SE, Rich JD. Development of an incarceration-specific overdose prevention video: Staying Alive on the Outside. Health Educ J. 2015; 74: 627-637.
29. Stetler CB, Damschroder LJ, Helfrich CD, Hagedorn HJ. A guide for applying a revised version of the PARIHS framework for implementation. Implement Sci. 2011; 6: 99.
30. Morgan DL. The Focus Group Guidebook. Thousand Oaks, CA: Sage Publications; 1997.
31. Miles MB, Huberman AM, Saldaña J. Qualitative Data Analysis: A Methods Sourcebook. Thousand Oaks, CA: Sage Publications; 2013.
32. Mosher HJ, Krebs EE, Carrel M, Kaboli PJ, Weg MW, Lund BC. Trends in prevalent and incident opioid receipt: An observational study in Veterans Health Administration 2004-2012. J Gen Intern Med. 2015; 30: 597-604.
33. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315-1321.
34. Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: The VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007; 102: 1954-1959.
35. Gossop M, Green L, Phillips G, Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry. 1989; 154: 348-353.
36. Advisory Council on the Misuse of Drugs. Consideration of Naloxone. London: Advisory Council on the Misuse of Drugs; 2012.
37. Davis CS, Walley AY, Bridger CM. Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina. J Law Med Ethics. 2015; 43 (Suppl 1): 19-22.
38. Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: A retrospective cohort study. BMC Public Health. 2014; 14: 297.
39. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, Rosenthal DM. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav. 2006; 31: 907-912.
40. Strang J, Powis B, Best D, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction. 1999; 94: 199-204.
41. Humphreys K. An Overdose Antidote Goes Mainstream. Health Aff. (Millwood). 2015; 34: 1624-1627. Available at: http://content.healthaffairs.org/content/34/10/1624.full.html. Accessed October 10, 2015.
42. Davis CS, Carr D. Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug Alcohol Depend. 2015; 157: 112-120.
43. Davis CS, Carr D, Southwell JK, Beletsky L. Engaging law enforcement in overdose reversal initiatives: Authorization and liability for naloxone administration. Am J Public Health. 2015; 105: 1530-1537.
44. Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: A national systematic legal review. Acad Emerg Med. 2014; 21: 1173-1177.
45. American Society of Anesthesiologists. Opioid Overdose Resuscitation Card. Accessed 2/26/16. https://www.asahq.org/WhenSecondsCount/resources.aspx
46. Wheeler M, Monks A. Narcan saves lives: I am the evidence-Brian. https://www.youtube.com/watch?v=L1lyaOoXZ0E. We Are the Evidence: Massachusetts.
47. Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013; 154: 2287-2296.